Who is best benefited by radical prostatectomy?

Hematology/Oncology Clinics of North America

Volumn 10, Issue 3, 1996, Pages 581-593

  Nadler, R B ^a   Andriole, G L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0029939474     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70354-3     Document Type: Article

References (39)

1. G. Aus J. Hugosson L. Norlen Long-term survival and mortality in prostate cancer treated with non-curative intent J Urol 154 1995 460 465
2. G. Aus J. Hugosson L. Norlen Need for hospital care and palliative treatment for prostate cancer treated with non-curative intent J Urol 154 1995 466 469
3. W.J. Catalona D.S. Smith 5 Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer J Urol 152 1994 1851 1842
4. W.J. Catalona J.P. Richie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men J Urol 151 1994 1283 1290
5. W.J. Catalona D.S. Smith T.L. Ratliff J.W. Basler Detection of organ-confined prostate cancer is increased through prostate specific antigen-based screening JAMA 27 1993 948 954
6. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161
7. G.W. Chodak R.A. Thisted G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242 248
8. M.R. Cupp D.G. Bostwick R.P. Myers J.E. Oesterling The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis J Urol 153 1995 1543 1548
9. D.D. Dietrick J.E. McNeal T.A. Stamey Core cancer length in ultrasound-guided systematic sextant biopsies: A preoperative evaluation of prostate cancer volume Urology 45 1995 987 992
10. J.I. Epstein P.C. Walsh M. Carmichael C.B. Brendler Pathologic and clinical findings to predict tumor extent of nonpalpable (Stage T1c) prostate cancer JAMA 271 1994 368 374
11. J.R. Goad S.J. Chang M. Ohori P.T. Scardino PSA after definitive radiotherapy for clinically localized prostate cancer Urol Clin North Am 20 1993 727 736
12. P.A. Humphrey J. Baty D. Keetch Relationship between serum prostate specific antigen, needle biopsy findings, and histopathological features of prostatic carcinoma in radical prostatectomy tissues Cancer 75 1995 1842 1849
13. J.E. Johansson Expectant management of early stage prostatic cancer: Swedish experience J Urol 152 1994 1753 1756
14. J.E. Johansson H.O. Adami S. Andersson High 10 year survival rate in patients with early, untreated prostate cancer JAMA 267 1992 2191 2196
15. G.W. Jones C. Mettlin G.P. Murphy Patterns of care for carcinoma of the prostate gland: Results of a national survey of 1984 and 1990 J Am Coll Surg 180 1995 545 554
16. J.N. Kabalin J.E. McNeal H.M. Price Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: Incidence, histology and morphometric observations J Urol 141 1989 1091 1094
17. I.D. Kaplan R.S. Cox M.A. Bagshaw Prostate specific antigen after external beam radiotherapy for prostatic cancer: Follow-up J Urol 149 1993 519 522
18. J.E. Montie D.P. Wood J.E. Pontes Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer Cancer 63 1989 381 385
19. R.P. Myers J.R. Goellner D.R. Cahill Prostate slope, external strictured ureteral sphincter and radical prostatectomy: The apical dissection J Urol 138 1987 543
20. M. Ohori J.R. Goad T.M. Wheeler Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152 1994 1843 1849
21. A.W. Partin C.R. Pound J.Q. Clemens Serum PSA following anatomical radical prostatectomy: The Johns Hopkins experience after 10 years Urol Clin North Am 20 1993 713
22. A.W. Partin J. Yoo H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110 114
23. P.A. Peller D.C. Young D.P. Marmaduke Sextant prostate biopsies, a histopathologic correlation with radical prostatectomy specimens Cancer 75 1995 530 538
24. A.R. Rich On the frequency of occult carcinoma of the prostate J Urol 33 1935 215 223
25. H.P. Schmid J.E. McNeal T.A. Stamey Observations on the doubling time of prostate cancer: The use of several prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume Cancer 71 1993 7031 7040
26. E. Silverberg J. Lubera Cancer Statistics, 1986 Cancer 36 1986 9 18
27. T.A. Stamey Making the most out of six systematic sextant biopsies Urology 45 1995 2 12
28. T.A. Stamey M.K. Ferrari H.P. Sermid The value of serial prostate specific antigen determinations 5 years after radiotherapy: Steeply increasing values characterize 80% of patients J Urol 150 1993 1856 1859
29. T.A. Stamey F.S. Freiha J.E. McNeal Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 71 1993 933 938
30. G.D. Steele J.M. Jessup D.P. Winchester National Cancer Data Base: Annual Review of Patient Care 1995 American Cancer Society Atlanta
31. M.K. Terris D.J. Henry I.M. Johnstone Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound and systematic sextant biopsies Urology 45 1995 75 80
32. P.C. Walsh P.J. Donker Impotence following radical prostatectomy: Insight into etiology and precaution J Urol 128 1982 492
33. P.C. Walsh A.W. Partin J.I. Epstein Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results of 10 years J Urol 152 1994 1831 1836
34. P.C. Walsh D.M. Quinlan R.A. Morton M.S. Steiner Radical retropubic prostatectomy: Improved anastomosis and urinary continence Urol Clin North Am 17 1990 679
35. J. Warner W.F. Whitmore Expectant management of clinically localized prostate cancer J Urol 152 1994 1761 1765
36. W.F. Whitmore Jr J.A. Warner I.M. Thompson Jr Expectant management of localized prostate cancer Cancer 67 1991 1091 1096
37. S.L. Parker T. Tong S. Bolden Cancer statistics 1996 Cancer 46 1996 5 27
38. G.K. Zagars Serum PSA as a tumor marker for patients undergoing definitive radiation therapy Urol Clin North Am 20 1993 737 747
39. G.K. Zagars A.C. vonEschenbach Prostate specific antigen: An important marker for prostate cancer treated by external beam radiotherapy Cancer 72 1993 5 8